BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 530882)

  • 41. [1st considerations on determination of immunoglobulins in some liver diseases].
    De Simone E
    Rass Int Clin Ter; 1971 Jun; 51(12):742-7. PubMed ID: 4105759
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil].
    Paz MO; Galizzi Filho J; Simonetti JP; Simonetti SR; de Santana ZM; Barbosa MM; de Carvalho DG; Toppa NH
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(6):311-6. PubMed ID: 10413947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The different biochemical course of HBsAg-negative and HBsAg-positive hepatitis (author's transl)].
    Strohm WD; Hossenfelder E; Stille W
    Z Gastroenterol; 1978 Jan; 16(1):13-23. PubMed ID: 74913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunoglobulins in viral hepatitis].
    Il'inskiĭ IuA; Skvortsov VM; Dvurechenskaia GS; Luchshev VI; Nikiforov ND
    Sov Med; 1981; (9):41-3. PubMed ID: 7313793
    [No Abstract]   [Full Text] [Related]  

  • 45. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.
    Lam KC; Lai CL; Trepo C; Wu PC
    N Engl J Med; 1981 Feb; 304(7):380-6. PubMed ID: 7005678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chronic persistent HBsAg positive hepatitis in children. II. Effect of treatment with levamisole].
    Masi M; Paolucci P; Timoncini G; Fantini MP; Chiodo F; Franceschi C
    Boll Ist Sieroter Milan; 1978 Sep; 57(4):471-6. PubMed ID: 310686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prevalence of hepatitis A, B, C and E virus markers among patients with elevated levels of Alanine aminotransferase and Aspartate aminotransferase in Phnom Penh (Cambodia) and Nha Trang (Central Vietnam)].
    Buchy P; Monchy D; An TT; Srey CT; Tri DV; Son S; Glaziou P; Chien BT
    Bull Soc Pathol Exot; 2004 Aug; 97(3):165-71. PubMed ID: 15462195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subtypes of Australia antigen in persistent Australia antigenemia and sporadic hepatitis among patients with lepromatous leprosy and their segregated children with no apparent clinical illness.
    Saha K; Dutta RN
    Int J Lepr Other Mycobact Dis; 1977; 45(1):38-48. PubMed ID: 68939
    [No Abstract]   [Full Text] [Related]  

  • 49. [Surface antigen (HBsAg) and core antigen (HBcAg) of the Dane particle detected by immunofluorescence in hepatic biopsies in patients with acute and chronic hepatitis].
    Rizzetto M; Bonino F; Toselli M; Verme G
    Minerva Gastroenterol; 1976; 22(3):241-4. PubMed ID: 794760
    [No Abstract]   [Full Text] [Related]  

  • 50. [Progressive dementia associated with vision and gait disorders (Kuf's syndrome?)].
    Perris C; Strandqvist B
    Psychiatr Neurol Med Psychol (Leipz); 1969 Oct; 21(10):380-4. PubMed ID: 5363773
    [No Abstract]   [Full Text] [Related]  

  • 51. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
    Krishnamurthy G; Kher V; Naik S
    Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seroprevalence and biochemical features of hepatitis B surface antigenemia in patients with HIV-1 infection in Lagos, Nigeria.
    Iwalokun BA; Hodonu SO; Olaleye BM; Olabisi OA
    Afr J Med Med Sci; 2006 Sep; 35(3):337-43. PubMed ID: 17312742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fulminant viral hepatitis (type B) in the late stage of pregnancy showing an unusual pattern of serum antigen and antibody: report of a case.
    Nakamura F; Sasaki H; Ueda M; Yamanoue M; Kajihara H
    Hiroshima J Med Sci; 1988 Mar; 37(1):45-9. PubMed ID: 3410735
    [No Abstract]   [Full Text] [Related]  

  • 54. [Serum enzymes and HBsAg in families with viral hepatitis].
    Spies K; Beck R; Püschel J; Friedeman H
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(2):145-54. PubMed ID: 562368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic delta hepatitis: a difficult problem for the hepatologist.
    Picciotto A; Celle G
    Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
    Lampe K; Hüdepohl M; Schopen RD
    Med Klin; 1972 Apr; 67(15):527-34. PubMed ID: 5053009
    [No Abstract]   [Full Text] [Related]  

  • 57. [Chronic HBs-Ag-positive hepatitides in children. Values and trends of main immunoglobulin classes in a longitudinal study].
    Cihula J; Turková M; Plachý V
    Cesk Pediatr; 1979 Feb; 34(2):68-72. PubMed ID: 427962
    [No Abstract]   [Full Text] [Related]  

  • 58. [The diagnostic significance of immunoglobulin determination in chronic liver diseases. I. Differential diagnostic accuracy of immunoglobulin changes and enzyme activities (author's transl)].
    Ortmans H; Wildhirt E; Welcke U; Tücke M
    MMW Munch Med Wochenschr; 1975 Oct; 117(42):1681-8. PubMed ID: 241934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SH (Australia) antigen in early life.
    Turner GC; Field AM; Lasheen RM; Tood RM; White GB; Porter AA
    Arch Dis Child; 1971 Oct; 46(249):616-22. PubMed ID: 5118049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitation of immunoglobulin-associated HBs antigen in patients with acute and chronic hepatitis, in healthy carriers and in polyarteritis nodosa.
    Lambert PH; Tribollet E; Celada A; Madalinski K; Frei PC; Miescher PA
    J Clin Lab Immunol; 1980 Jan; 3(1):1-8. PubMed ID: 6103964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.